inositol has been researched along with Absence Status in 7 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We have previously shown that myoinositol (MI) daily treatment for 28 days prevents certain biochemical changes that are triggered by kainic acid (KA) induced status epilepticus (SE)." | 7.83 | Myoinositol Attenuates the Cell Loss and Biochemical Changes Induced by Kainic Acid Status Epilepticus. ( Kikvidze, M; Lepsveridze, E; Lordkipanidze, T; Nozadze, M; Solomonia, R; Tsverava, L, 2016) |
| "It is known that myo-inositol pretreatment attenuates the seizure severity and several biochemical changes provoked by experimentally induced status epilepticus." | 7.79 | The protective effect of myo-inositol on hippocamal cell loss and structural alterations in neurons and synapses triggered by kainic acid-induced status epilepticus. ( Bikashvili, T; Bolkvadze, T; Japaridze, NJ; Kiladze, M; Kotaria, N; Solomonia, RO; Zhvania, MG, 2013) |
| " We have previously shown that myo-Inositol (MI) daily treatment prevents certain biochemical changes that are triggered by kainic acid (KA)-induced status epilepticus (SE)." | 7.79 | Myo-inositol treatment and GABA-A receptor subunit changes after kainate-induced status epilepticus. ( Dzneladze, D; Gogichaishvili, N; Kiguradze, T; Lepsveridze, E; Nozadze, M; Solomonia, R, 2013) |
| " In this study, we investigated the metabolism in the thalamus to identify the changes that occur following Coriaria lactone (CL)-induced status epilepticus (SE) and to observe whether the epileptiform discharges could present a difference between the left and right thalami." | 7.78 | Longitudinal ¹H MRS assessment of the thalamus in a Coriaria lactone-induced rhesus monkey status epilepticus model. ( Gong, QY; Li, HX; Li, JM; Wang, L; Yang, ZY; Zhang, XY; Zhou, D, 2012) |
| " We have previously shown that myoinositol (MI) daily treatment for 28 days prevents certain biochemical changes that are triggered by kainic acid (KA) induced status epilepticus (SE)." | 3.83 | Myoinositol Attenuates the Cell Loss and Biochemical Changes Induced by Kainic Acid Status Epilepticus. ( Kikvidze, M; Lepsveridze, E; Lordkipanidze, T; Nozadze, M; Solomonia, R; Tsverava, L, 2016) |
| "It is known that myo-inositol pretreatment attenuates the seizure severity and several biochemical changes provoked by experimentally induced status epilepticus." | 3.79 | The protective effect of myo-inositol on hippocamal cell loss and structural alterations in neurons and synapses triggered by kainic acid-induced status epilepticus. ( Bikashvili, T; Bolkvadze, T; Japaridze, NJ; Kiladze, M; Kotaria, N; Solomonia, RO; Zhvania, MG, 2013) |
| " We have previously shown that myo-Inositol (MI) daily treatment prevents certain biochemical changes that are triggered by kainic acid (KA)-induced status epilepticus (SE)." | 3.79 | Myo-inositol treatment and GABA-A receptor subunit changes after kainate-induced status epilepticus. ( Dzneladze, D; Gogichaishvili, N; Kiguradze, T; Lepsveridze, E; Nozadze, M; Solomonia, R, 2013) |
| " In this study, we investigated the metabolism in the thalamus to identify the changes that occur following Coriaria lactone (CL)-induced status epilepticus (SE) and to observe whether the epileptiform discharges could present a difference between the left and right thalami." | 3.78 | Longitudinal ¹H MRS assessment of the thalamus in a Coriaria lactone-induced rhesus monkey status epilepticus model. ( Gong, QY; Li, HX; Li, JM; Wang, L; Yang, ZY; Zhang, XY; Zhou, D, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kotaria, N | 1 |
| Kiladze, M | 1 |
| Zhvania, MG | 1 |
| Japaridze, NJ | 1 |
| Bikashvili, T | 1 |
| Solomonia, RO | 1 |
| Bolkvadze, T | 1 |
| Wu, Y | 1 |
| Pearce, PS | 1 |
| Rapuano, A | 1 |
| Hitchens, TK | 1 |
| de Lanerolle, NC | 1 |
| Pan, JW | 1 |
| Tsverava, L | 1 |
| Lordkipanidze, T | 1 |
| Lepsveridze, E | 3 |
| Nozadze, M | 3 |
| Kikvidze, M | 1 |
| Solomonia, R | 3 |
| Rabeson, H | 1 |
| Fauvelle, F | 1 |
| Testylier, G | 1 |
| Foquin, A | 1 |
| Carpentier, P | 1 |
| Dorandeu, F | 1 |
| van Ormondt, D | 1 |
| Graveron-Demilly, D | 1 |
| Mikautadze, E | 1 |
| Kuchiashvili, N | 1 |
| Kiguradze, T | 2 |
| Zhang, XY | 1 |
| Yang, ZY | 1 |
| Li, JM | 1 |
| Li, HX | 1 |
| Wang, L | 1 |
| Gong, QY | 1 |
| Zhou, D | 1 |
| Gogichaishvili, N | 1 |
| Dzneladze, D | 1 |
7 other studies available for inositol and Absence Status
| Article | Year |
|---|---|
The protective effect of myo-inositol on hippocamal cell loss and structural alterations in neurons and synapses triggered by kainic acid-induced status epilepticus.
Topics: Analysis of Variance; Animals; Cell Count; Cerebrum; Dendrites; Hippocampus; Inositol; Kainic Acid; | 2013 |
Metabolic changes in early poststatus epilepticus measured by MR spectroscopy in rats.
Topics: Animals; Antigens, Nuclear; Aspartic Acid; Brain Chemistry; Creatine; Epilepsy, Temporal Lobe; Gluta | 2015 |
Myoinositol Attenuates the Cell Loss and Biochemical Changes Induced by Kainic Acid Status Epilepticus.
Topics: Animals; Blotting, Western; Calibration; Caspase 3; Cell Count; Hippocampus; Inositol; Kainic Acid; | 2016 |
Quantitation with QUEST of brain HRMAS-NMR signals: application to metabolic disorders in experimental epileptic seizures.
Topics: Acetates; Alanine; Algorithms; Animals; Aspartic Acid; Brain; Choline; gamma-Aminobutyric Acid; Glut | 2008 |
Myo-inositol treatment prevents biochemical changes triggered by kainate-induced status epilepticus.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Convulsants; Hippocampus; HSP90 Heat-Sh | 2010 |
Longitudinal ¹H MRS assessment of the thalamus in a Coriaria lactone-induced rhesus monkey status epilepticus model.
Topics: Animals; Creatinine; Disease Models, Animal; Glutamic Acid; Inositol; Lactones; Macaca mulatta; Magn | 2012 |
Myo-inositol treatment and GABA-A receptor subunit changes after kainate-induced status epilepticus.
Topics: Animals; Inositol; Kainic Acid; Male; Protein Subunits; Rats; Rats, Wistar; Receptors, GABA-A; Statu | 2013 |